Jay S. Cooper - Concepedia

Author

Jay S. Cooper

Also Known As

Cooper, Jay S., J COOPER, J Cooper, J S Cooper, J. Cooper, J. S. Cooper, J.S Cooper, J.S. Cooper, J.S.S. Cooper, JAY S. COOPER

427

Publications

31.1K

Citations

H-Index

Concepts

All Affiliations

New York University RTOG Foundation Columbia University Irving Medical Center Maimonides Medical Center The University of Texas MD Anderson Cancer Center

About

Jay S. Cooper is an author at New York University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	49	7.3K
2	Health Sciences	22	29	6K
3	Engineering	3	3	200
4	Public Health	2	2	265
5	Cell Biology	1	1	27

Jay S. Cooper

100

Publications

29.1K

Citations

H-Index

Page 1

	Year	Citations
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, New England Journal of Medicine	2004	3.2K
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor, New England Journal of Medicine	2003	3.1K
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri, Journal of Clinical Oncology	1998	2.2K
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus Arnold Herskovic, Karen Martz, Muhyi Al‐Sarraf, New England Journal of Medicine	1992	2.1K
Chemoradiotherapy of Locally Advanced Esophageal Cancer Jay S. Cooper, Matthew Guo, Arnold Herskovic, JAMA	1999	1.9K
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Jacques Bernier, Jay S. Cooper, Thomas F. Pajak, Head & Neck Surgical OncologyExtracapsular ExtensionSurgeryOnly Risk FactorsRadiation Medicine	2005	1.7K
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Karen K. Fu, Thomas F. Pajak, Andy Trotti, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineAccelerated FractionationRadiation TherapyFractionation RadiotherapyMedicine	2000	1.4K
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis Mitchell Machtay, Jennifer Moughan, A. Trotti, Journal of Clinical Oncology	2008	1.3K
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer Arlene A. Forastiere, Qiang Zhang, Randal S. Weber, Journal of Clinical Oncology	2012	1.3K
Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01 Patricia J. Eifel, Kathryn Winter, Mitchell Morris, Journal of Clinical Oncology	2004	1K

Page 1